🖊️ A AbbVie assinou a Carta Portuguesa para a Diversidade! Com este gesto, reforçamos o compromisso da AbbVie e de todos os nossos colaboradores com a Equidade, Igualdade, Inclusão e Diversidade. Acreditamos que as características que nos distinguem devem ser celebradas – e não reprimidas – e que cada indivíduo apresenta uma perspetiva única e fundamental para a construção de um ambiente inclusivo e respeitador. ✨ O nosso agradecimento à APPDI - Associação Portuguesa para a Diversidade e Inclusão por ter partilhado connosco a sua missão e por nos inspirar a ser uma empresa cada vez melhor. #EEDI #AbbVieLife
About us
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
- Website
-
http://www.abbvie.com
External link for AbbVie
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- North Chicago, Illinois
- Type
- Public Company
- Specialties
- Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care
Locations
Employees at AbbVie
Updates
-
A #BloodCancer diagnosis can have a life-changing impact on patients and their families. Hear how Esther’s life transformed after a diffuse large B-cell #lymphoma (DLBCL) diagnosis and what keeps her motivated. [Video description: Esther, DLBCL patient, discusses her journey of being diagnosed with DLBCL and the importance of research in the blood cancer space.]
-
Inflammatory bowel disease (#IBD) is a complex condition that can have a profound impact on a person’s mental and physical well-being. To learn more about the importance of optimal disease management, explore our excerpt in the October edition of the European Federation of Crohn's and Ulcerative Colitis Associations magazine: https://bit.ly/3BpFDHQ
-
Today is Rosh Hashanah, the Jewish New Year festival marking the beginning of the Jewish High Holidays. Phillip Shapiro, franchise research & analytics manager, shares how he celebrates with his family, his community and around the office. #BelongAtAbbVie [Video description: Phillip Shapiro, an AbbVie employee, shares how he celebrates Rosh Hashanah and Yom Kippur with his family, community and colleagues.]
-
#LiverCancer is the sixth most common cancer worldwide, and #HepatitisC is one of the major risk factors. With prevention, testing and treatment services available around the world, #HepatitisC elimination by 2030 is within reach. October is #LiverCancerAwarenessMonth and we’re raising awareness of #LiverCancer and #HCV. Learn more ⬇ [Video description: An interview with Homie Razavi, Managing Director, Center for Disease Analysis Foundation. On-screen text reads, “Scaling up Hepatitis C testing and treatment can save the world $23 billion in productivity losses, reduce healthcare spending and prevent an estimated 10 million new infections worldwide. Join us in the movement to eliminate Hepatitis C.”]
-
This National Disability Employment Awareness Month, hear members of our Ability employee resource group share the importance of accessibility in the workplace. Learn more about how Ability empowers people to reach their full potential : https://bit.ly/4gQwQ27 #BelongAtAbbVie #NDEAM [Video Description: Members of the ABILITY employee resource group at AbbVie share personal stories about workplace accessibility, diversity and providing opportunities for professionals of all abilities.]
-
During #BloodCancerAwarenessMonth and year-round, we are committed to the patients worldwide living with difficult-to-treat cancers. Hear from one of the many voices of those impacted by blood cancers, Esther, who is living with diffuse large B-cell #lymphoma. [Video description: Esther, person living with DLBCL, discusses her journey of living with DLBCL as a single mom.]
-
Today at this year’s International Parkinson and Movement Disorder Society Congress, we're showcasing the Phase 3 clinical trial results in #ParkinsonsDisease. Learn more about our work in neuroscience: https://bit.ly/3N22RGL #MDS2024
-
At this year’s International Parkinson and Movement Disorder Society Congress, we’re presenting data from our expanding movement disorder portfolio, including #ParkinsonsDisease, spasticity and cervical dystonia. Join us at booth 501 to explore our novel research and learn more about our newly acquired portfolio from Cerevel Therapeutics at booth 302. #MDS2024 [Video description: On-screen text reads, “Join us at the International Congress of Parkinson’s Disease and Movement Disorders September 27-October 1, Philadelphia, PA. Sharing 17 abstracts supporting Parkinson's disease, cervical dystonia and spasticity.” Followed by dates and times of AbbVie Symposium and Cerevel Symposium.]
Affiliated pages
Similar pages
Browse jobs
Stock
ABBV
NYSE
20 minutes delay
$193.87
-1.58 (-0.808%)
- Open
- 194.98
- Low
- 193.045
- High
- 195.64
Data from Refinitiv
See more info on